Live tape
Top 8, mentions 7d6,374META1,842 mentions▲ +0.06GOOGL1,291 mentions▲ +0.02NVDA747 mentions▲ +0.09MSFT557 mentions▲ +0.05MUSE513 mentions▲ +0.06TSLA497 mentions▲ +0.05SPY484 mentions▲ +0.03QQQ443 mentions▲ +0.07

Equity · Healthcare

DVA

NYSE

DaVita Inc.

$178.38 +2.09% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Sep 25, 2026
Price · Chart
Our own end-of-day closes 61 sessions
$250 $150 1 Jul 25 Sep

The line runs $228 on 1 July through $178.38 on 25 September, on a scale from $150 to $250. Days the market did not trade hold the previous close, flat.

The chart above plots the price of DVA over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 61 sessions over that window: $228 on 1 July 2026 through $178.38 on 25 September 2026.

Market cap $11.4B
P/E (TTM) 14.7
52-week range $103.92 – $241
Avg volume 33.6K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Sep 25, 2026

DVA insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 22 Sep 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 9

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
22 Sep 2026 Maughan David Paul Chief Operating Officer, DKC Tax withheld 7,501 $1.37M
15 Aug 2026 Arway Pamela M Director Award 278
15 Aug 2026 YALE PHYLLIS R Director Award 278
15 Aug 2026 Schoppert Wendy Lee Director Award 278
15 Aug 2026 Pullin Dennis W Director Award 278
15 Aug 2026 Moore Gregory J. Director Award 278
15 Aug 2026 Schechter Adam H Director Award 278
15 Aug 2026 DESOER BARBARA J Director Award 278
15 Aug 2026 Hollar Jason M. Director Award 278

DVA reported financials

SEC EDGAR XBRL

DVA reported revenue of $13.6B for the fiscal year ended 31 Dec 2025. Net income over the same period was $746.8M.

Figure Reported Period
Revenue $13.6B 31 Dec 2025 fiscal year
Net income $746.8M 31 Dec 2025 fiscal year
Diluted EPS $9.84 31 Dec 2025 fiscal year
Total assets $17.7B 30 Jun 2026 at period end
Total equity −$765.1M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

DVA earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $4.02 $3.55B
31 Mar 2026 Q1 2026 $2.87 $3.42B
31 Dec 2025 FY 2025 $9.84 $13.64B
30 Sep 2025 Q3 2025 $2.04 $3.42B
30 Jun 2025 Q2 2025 $2.58 $3.38B
31 Mar 2025 Q1 2025 $2.00 $3.22B
31 Dec 2024 FY 2024 $10.73 $12.82B
30 Sep 2024 Q3 2024 $2.50 $3.26B

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

DVA institutional holders

SEC Form 13F

10 of the 45 institutional funds we track reported a DVA position for the quarter ended 30 Jun 2026 — a combined $6.8B; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Berkshire Hathaway Held (±25%) −4.1% shares 28,880,209 $6.4B
D. E. Shaw & Co. Added +27.0% shares 640,827 $142.6M
AQR Capital Management Added +43.4% shares 587,758 $128.1M
Citadel Advisors Trimmed −72.2% shares 199,862 $44.5M
Millennium Management Added +40.2% shares 77,094 $17.2M
Tudor Investment Corp Trimmed −25.1% shares 59,895 $13.3M
Marshall Wace Added +2,324.2% shares 36,897 $8.2M
Two Sigma Investments Trimmed −58.8% shares 20,230 $4.5M
Bridgewater Associates Trimmed −47.4% shares 10,996 $2.4M
Renaissance Technologies Trimmed −96.6% shares 6,400 $1.4M

Source: SEC EDGAR 13F filings

DVA fails-to-deliver

SEC CNS data

On 28 Aug 2026, 259 shares of DVA failed to deliver (about $46K) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
28 Aug 2026 259 $46K <0.001%
27 Aug 2026 319 $57K 0.001%
25 Aug 2026 1 $177 <0.001%
17 Aug 2026 375 $68K 0.001%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in DVA

STOCK Act disclosures

The most recent congressional trade disclosed in DVA is a purchase by Julie Johnson (house, TX), dated 23 Sep 2025.

Date Member Type Amount
23 Sep 2025 filed 05 Aug 2026 Julie Johnson house · Democrat–TX Purchase $1K–$15K

Source: U.S. House of Representatives financial disclosures